Mandate

Vinge advises Stiftelsen Industrifonden on the investment in Airsonett AB

August 23, 2007

Industrifonden and SEB will make a joint investment of MSEK 55 and the existing shareholders will invest the remaining MSEK 15 in Airsonett AB, a medical technology company. Airsonett AB carries out research and develops non-pharmaceutical aids reducing the allergen and other air pollution.

Stiftelsen Industrifonden is represented by partner Johan Winnerblad and Johan Larsson.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026